Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy - Concepedia

Concepedia

Publication | Open Access

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

DOI Full Paper Access

628

Citations

23

References

2010

Year

José Baselga, Karen A. Gelmon, Shailendra Verma, Andrew Wardley, Pierfranco Conté, David Miles, Giulia Bianchi, Javier Cortés, Virginia McNally, Graham Ross,

Journal of Clinical Oncology

Abstract

The combination of pertuzumab and trastuzumab is active and well tolerated in patients with metastatic HER2-positive breast cancer who had experienced progression during prior trastuzumab therapy.

References

	Year	Citations

Page 1